Tanveer Ashraf

With over 9 years of experience, successfully managed and led 10+ research projects, resulting in a 40% reduction in project delays within 5 years. Developed and optimized RIA protocols, leading to an increase in assay sensitivity and accuracy within 3 years. Published more than 15 scientific studies and abstracts.

• ACRP-CP
• ICH-GCP

• Award for 'Active Research Site based on Number of Publications for 2022'- Department of Health, Abu Dhabi
• Novel human studies- Pro Neurotensin project in healthy and diabetes participants
• Identifications of novel mutations under Abu Dhabi Obesity Study (ADOS)
• Challenges in insulin resistance: impact of bariatric surgery

• First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-World Clinical Settings in a Middle East Population, Clinical Therapeutics, 12/2023
• Fructosamine as a predictor of incident diabetic microvascular disease in a population with high prevalence of red cell disorders: a cohort study, Diabetes Research and Clinical Practice, 08/2023
• Inclisiran for the treatment of hypercholesterolemia in clinical settings, British Endocrine Society, 08/2022
• The effect of COVID-19 pandemic lockdown and the overlapping Ramadan fasting period on glucose control in insulin-treated patients with diabetes: a flash glucose monitoring study, Frontiers in Nutrition, 03/2022
• A case of Cardiac transthyretin amyloidosis, Journal of the American Society of Echocardiography (JASE)/Cardiovascular Imaging Case Reports (CASE), 04/2022
• An analysis of flash glucose monitoring (FGM) data on insulin-treated patients with diabetes: effects of COVID-19 lockdown, European Congress of Endocrinology, 02/2021
• Diabetes and Ramadan: utility of flash-glucose monitoring derived markers of glycemic control and comparison with glycosylated hemoglobin, Diabetes Research and Clinical Practice, 2019
• Obesity and cognitive function in children and adolescents: relevance of sociology-economic factors, European Association for the Study of Obesity, 05/2021
• In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula, International Journal of Infectious Diseases, 07/2020
• Lipoatrophy in a patient with type 1 diabetes: genetic or immunological?, European Congress of Endocrinology, 07/2020
• Progressive weight gain to a BMI of 89 kg/m2 following a road traffic accident: a collusion of nature and nurture?, European and International Congress on Obesity, 07/2020
• Glycaemic response to a mixed meal challenge: does camel milk preload confer an advantage?, Endocrine Abstracts, 2019
• Permanent Neonatal Diabetes due to NKX2-2 Mutation: first report from UAE, European Association for the Study of Diabetes, 2019
• Dramatic weight loss after sleeve gastrectomy in a patient with obesity due to heterozygous leptin receptor mutation, European Congress of Obesity, 04/2019
• Plasmid-mediated colistin resistance gene mcr-1 in an Escherichia coli ST10 bloodstream isolate, Microbial Drug Resistance, 2019
• Carbapenem Resistant Enterobacteriaceae in Abu Dhabi & Al Ain, 01/2018

• ACRP-CP, ACRP - Association of Clinical Research Professionals
• Good Clinical Practice, NIDA Clinical Trials Network
• Transforming Patient Care in Diabetes, Genomic Medicine UK
• IMPERIAL Genomics FRCPath MASTERCLASS, Imperial College London, UK